StockVS

Cartesian Growth Corporation III (CGCT) Aandelenanalyse

Financiële Diensten

Cartesian Growth Corporation III

$10.85

+$0.99 (+10.04%)

Laatst bijgewerkt: 26 mei 2026

Koersverloop

Analyse

Bedrijfsoverzicht

Cartesian Growth Corporation III is a special purpose acquisition company (SPAC) that does not maintain significant ongoing operations, instead focusing exclusively on executing a merger, amalgamation, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more external entities. The company operates within the Financial Services sector and specifically within the Shell Companies industry, a classification that indicates the entity currently serves as a financial vehicle awaiting a target acquisition rather than generating revenue through traditional commercial activities. As of the latest available data, the market capitalization stands at $353.97M, while the annual revenue is not applicable due to the lack of significant operating history, and the employee count is listed as N/A. These valuation metrics combined with the absence of traditional revenue streams indicate that the company's primary market position is defined by its potential to become a public shell, where its value is derived from the prospect of future business combinations rather than current operational performance or established market share.

Financiële gezondheid

The financial statements reflect the transitional nature of the entity, with reported revenue at N/A and net income standing at $6.22M, while EBITDA figures are not applicable. The significant gap between the reported net income of $6.22M and the non-existent revenue highlights a cost structure driven entirely by non-operational expenses or adjustments rather than the cost of goods sold, as the gross margin is recorded at 0.0%. Consequently, the operating margin and profit margin are also both 0.0%, indicating that the company generates no operating profit from traditional business activities and that the reported net income likely stems from non-operating sources such as warrant exercises or SPAC-specific accounting adjustments. The free cash flow is reported at $-244,656, suggesting a cash outflow that reflects the administrative costs of maintaining the public shell status rather than capital expenditures for operational growth. In terms of liquidity and leverage, the company holds $624,163 in cash against $0 in debt, resulting in a debt-to-equity ratio that is not applicable, which presents a highly conservative balance sheet free of traditional solvency risks. The current ratio stands at 0.89, indicating that current assets are slightly below current liabilities, a common characteristic for SPACs prior to a deal that may affect short-term liquidity planning. Return on assets is measured at -0.5%, while return on equity is not applicable, revealing that the management's effectiveness in generating returns is currently constrained by the asset-light, shell-based structure of the organization.

Waarderingsbeoordeling

The trailing twelve-month P/E ratio is 41.04, whereas the forward P/E ratio is not applicable, implying that the market is pricing in future earnings potential that cannot yet be quantified due to the lack of projected financial guidance. The price-to-book ratio is negative at -26.79, a figure that indicates the market is valuing the company significantly below its book value, likely reflecting the intrinsic value of the trust account assets rather than tangible operational assets. Since the price-to-sales ratio is not applicable and the EV/EBITDA is not applicable, these alternative valuation metrics suggest that standard multiple comparisons are invalid for this shell entity due to the absence of sales and EBITDA data. The stock's recent price range is bounded by a 52-week high of $10.42 and a 52-week low of $10.00. Without a specific current price provided in the source data, the exact percentage deviation from this range cannot be calculated, but the narrow spread between the high and low suggests low price volatility typical of non-trading or low-volume shell stocks. The beta value is not applicable, meaning that the company's price volatility relative to the broader market cannot be statistically determined from the available data.

Growth & Income

Revenue growth year-over-year and earnings growth year-over-year are both listed as N/A, preventing a direct comparison of how earnings are growing relative to revenue in the traditional sense. The company does not pay dividends, evidenced by a dividend yield of N/A and a payout ratio of 0.0%, which confirms that the entity retains all available earnings rather than distributing them to shareholders. Instead of providing income through dividends, the company reinvests its resources, if any exist beyond the trust, into the search for a target business combination to facilitate a merger or acquisition. The overall growth and income profile is characterized by a complete absence of historical growth metrics and income distribution, relying entirely on the successful execution of a future business combination to alter the company's fundamental nature and financial trajectory.

Vergelijking met sectorgenoten

Cartesian Growth Corporation III (CGCT) is actief in de Lege Vennootschappen-sector. Zo verhoudt het zich tot de naaste sectorgenoten op basis van marktkapitalisatie:

Bedrijf Ticker Marktkapitalisatie K/W-verhouding
Cartesian Growth Corporation III CGCT $449.19M 36.2
Twenty One Capital, Inc. XXI $2.49B N/A
Churchill Capital Corp X CCCX $711.00M N/A
Drugs Made In America Acquisition II Corp. DMII $641.46M 77.5

De gemiddelde K/W-verhouding in de Lege Vennootschappen-sector is 82.8x. Cartesian Growth Corporation III wordt verhandeld tegen een K/W van 36.2.

Deze analyse is gegenereerd door AI en dient alleen ter informatie. Het vormt geen financieel advies. Gegevens kunnen vertraagd of onnauwkeurig zijn. Doe altijd je eigen onderzoek en raadpleeg een gekwalificeerde financieel adviseur voordat je beleggingsbeslissingen neemt.

Over Cartesian Growth Corporation III

Cartesian Growth Corporation III does not have significant operations. It focuses on effecting a merger, amalgamation, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses or entities. Cartesian Growth Corporation III was incorporated in 2024 and is based in New York, New York.

Bedrijfsbeschrijving wordt in het Engels weergegeven.

Bezoek website →

Belangrijke Cijfers

Marktkapitalisatie
$449.19M
K/W-verhouding
36.17
52-weken hoog
$10.93
52-weken laag
$9.26
Gem. Volume
218.23K

Gegevens verstrekt door Yahoo Finance via yfinance. Dagelijks bijgewerkt.

Bedrijfsinfo

Beurs
NASDAQ
Land
United States